Navigation Links
Avastin under trial to test efficacy for pancreatic tumours!

Northwestern Memorial Hospital along with Northwestern University Feinberg School of Medicine is conducting a Phase II clinical trial to determine if avastin is effective in pancreatic tumours.//

The drug also known as bevacizumab is an anti-angiogenesis drug that is designed to inhibit the growth of blood vessels in tumours.

The test is being done to see that it in combination with abdominal radiation therapy and chemotherapy can reduce localized pancreatic tumours that have not metastasized or spread to other systems or organs in the body.

Northwestern Memorial is the sole clinical site where the research trial is being conducted.

"Our findings from the previous study suggest that the combination of chemotherapy and radiation is a safe and effective treatment method to reduce the local extent of pancreatic tumors," said Dr. Talamonti, MD, chief of the Division of Surgical Oncology at Northwestern Memorial Hospital, associate professor of surgery at Northwestern University Feinberg School of Medicine and co-investigator on the study

Another view was presented by William Small, Jr., MD, radiation oncologist, Northwestern Memorial Hospital, associate professor, Radiation Oncology, Northwestern University Feinberg School of Medicine and principal investigator for the trial, "The current study, which will be conducted over two years, will help us evaluate whether adding Avastin may also provide an effective combination to reduce the tumour and increase survival rates. Avastin is designed to inhibit Vascular Endothelial Growth Factor (VEGF), a protein that plays an important role in tumour angiogenesis or blood vessel formation, and maintenance of existing tumour vessels. By inhibiting VEGF, Avastin is thought to interfere with the blood supply to tumours, a process that is critical to tumour growth and metastasis.”

As per statistics by the American Cancer Society, pancreatic cancer is the fourth leading cause
'"/>




Page: 1 2

Related medicine news :

1. Avastin, anti-Cancer Drug leads to Blindness and Other Complications
2. Warning on Avastin Updated
3. FDA Approval for Lung Cancer Treatment -Avastin Along with Chemotherapy
4. Cancer Drug Avastin Fights Brain Tumors too
5. Antioxidants protect health tissue in people undergoing radiation therapy.
6. How do babies understand language?
7. Doctor samples come under the ambit of advertisement
8. Latest device for cardiac revival under test
9. Heart disease in women being under-treated
10. Safety of soy under suspicion
11. Education in women brings sounder sleep
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Avastin under trial test efficacy for pancreatic tumours

(Date:7/30/2014)... returning National Guard soldiers were more likely to ... life setbacks, including job loss, legal problems, divorce, ... military families. Results of the study by researchers ... are published online in the American Journal ... a major concern for reservists returning home. Nearly ...
(Date:7/30/2014)... combined immunodeficiency (SCID) can be successfully treated with a ... by Memorial Sloan Kettering,s Richard J. O,Reilly, MD, a ... review will be published in the July 30 issue ... , SCID is a group of inherited disorders that ... breakdown occurs, babies no longer have the ability to ...
(Date:7/30/2014)... Daily Gossip indicates in its 60 Second Panic ... attack is a feeling of intense stress and fear, which ... of symptoms that sufferers commonly deal with when panic attacks ... or anxiety. Naturally, panic attacks deeply affect lifestyle; this is ... them. , The 60 Second Panic Solution review promises to ...
(Date:7/30/2014)... DC and Malaysia (PRWEB) July 30, 2014 ... lives through education by LTT Global an award winning ... pioneering learning on the go since 2004. , MyMobileUni.com’s ... and quality learning content. MMU has links to ... universities, organizations, NGOs’ and subject matter experts from all ...
(Date:7/30/2014)... Washington, DC (PRWEB) July 30, 2014 ... PhD, RN, CNE, ANEF, who since September 2013 has ... Nursing , became the new dean of the College ... 14. The move marries her leadership of the NLN, ... one of the top-ranked academic nursing and research institutions ...
Breaking Medicine News(10 mins):Health News:Vets' alcohol problems linked to stress on the home front 2Health News:Transplantation shown to be highly effective in treating immune deficiency in children 2Health News:60 Second Panic Solution Review Reveals Unique Way to Stop Panic Attacks 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 3Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 2Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 3
... experimenting. Sometimes that means trying some risky behaviors. ... to cocaine, will be studied in their adolescent years. ... to using drugs, having sex or engaging in delinquent behaviors, ... exposure. The study will also closely follow the ...
... A study by researchers at the University of Leicester ... has hidden biases. Writing in the prestigious British ... how to spot ,publication bias, in the reporting of ... and NHS health policies. They also show what mathematical ...
... is an uncommon chronic liver disease characterized by progressive ... disease progresses slowly, usually leading to biliary cirrhosis, portal ... PSC is a common cause of adult cholestatic ... the liver transplantations in U.S. adults. At least ...
... , Editorial is a Call to Action for ... indicates that the social stigma that surrounds lesbian, gay, bisexual, and transgender ... use, risky sexual behaviors, eating disorders, suicidal ideation, and victimization. An editorial ... calls on clinicians and health researchers to lead the charge in improving ...
... CARDIFF, Calif., Aug.19 Rapi d ... plans to provide services to the medical cannabis industry. With ... the state of California, Rapid Fire Marketing has entered the ... to this newly-emerged industry, which includes medical doctors and cannabis ...
... , , NOVATO, Calif., Aug. ... today that data from clinical studies of Kuvan(R) (sapropterin dihydrochloride) and ... the International Congress of Inborn Errors of Metabolism (ICIEM) in San ... "We look forward to a number of abstracts, posters ...
Cached Medicine News:Health News:Longitudinal study investigates cocaine's impact on adolescent development 2Health News:Study finds adverse effects in treatment for primary sclerosing cholangitis 2Health News:Confronting Health Disparities Among Lesbian, Gay, Bisexual and Transgender Youth 2Health News:Confronting Health Disparities Among Lesbian, Gay, Bisexual and Transgender Youth 3Health News:Rapid Fire Marketing Enters Medical Cannabis Business 2Health News:Rapid Fire Marketing Enters Medical Cannabis Business 3Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 2Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 3Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 4Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 5Health News:Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 6
(Date:7/30/2014)... , July 30, 2014  There is ... chain organization,s success. The 10th Annual Institute for ... Awards for Excellence in Supply Management is open ... further the understanding and importance of supply management ... leadership and best supply management practices.  Entries are ...
(Date:7/30/2014)... -- CryoLife, Inc. (NYSE: CRY), a leading medical device ... surgery, announced today that its Board of Directors has ... 2014 of $0.03 per share of common stock outstanding.  ... be paid on September 19, 2014 to all common ... ex-dividend date for the quarterly dividend is September 10, ...
(Date:7/30/2014)... 2014 PuraMed BioScience ® , Inc., ... (OTC) medicinal and healthcare products, announced today that ... along with the name,s red and yellow logo. ... name MigraPure ®  going forward. The new ... natural migraine pain reliever will be reintroduced into ...
Breaking Medicine Technology:Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 3PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3
... Cyberonics, Inc. (Nasdaq: CYBX ), a global ... ended January 28, 2011.   Quarterly HighlightsOperating ... compared to the third quarter of fiscal 2010 include: ... U.S. net sales increased by 24%; U.S. epilepsy unit ...
... 1, 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... that Valeant Pharmaceuticals International ("Valeant"), its wholly owned indirect ... principal amount of senior unsecured notes (the "Notes"). ... Securities Act of 1933, as amended (the "Securities Act"), ...
Cached Medicine Technology:Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 2Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 3Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 4Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 5Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 6Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance 7Valeant Launches Senior Notes Offering 2Valeant Launches Senior Notes Offering 3
... free flowing powder. pH: pH(4.7%, H 2 ... 24% Yeast Extract: 47% Potassium Phosphate Dibasic: 25% ... Dissolve 47 gm powder per liter of purified ... DNA and recombinant proteins than LB media by ...
12% Tryptone, 24% Yeast Extract, 4.0% Glycerol. Supplied with 1 liter of 10x phosphate buffer (0190-1L)....
5.0% Casein digest (NZ amine), 2.5% Sodium Chloride, 2.5% Yeast Extract....
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride....
Medicine Products: